The World's First Multicenter Biobank Dedicated to Sarcopenia
What Is a Biobank?
M-Bank is the world's first multicenter biobank of older adults dedicated to patients with sarcopenia. Led by Wonju Severance Christian Hospital together with Kangbuk Samsung Hospital, it collects blood, muscle tissue, physical function, and clinical and genomic data in one integrated cohort, with 830 participants enrolled as of November 2026 toward a target of 3,000 by 2027. The accumulated data drives the advancement of MyoTest and the discovery of drug biomarkers, and Biobytes holds exclusive rights to use all data and outputs for 15 years.
Multicenter Collaboration Across Wonju Severance and Kangbuk Samsung Hospitals
Multicenter Collaboration
Comprehensive Data
Practical Applications
E-CRF System
Sarco-Finding
Core Biobank Capabilities
Data Collection Status
Total Participants830
Partner Institutions2
Related Patents4
Publications10
Monthly Participant Growth2025.03 - 2026.11
Total
79 people830 people
2025.03
2025.07
2025.11
2026.03
2026.07
2026.11
Monthly Sarcopenia Trends2025.03 - 2026.11
Proportion (%)
Participants with sarcopenia
11.4%20.6%
2025.03
2025.07
2025.11
2026.03
2026.07
2026.11
Participants by Age Group2025.03 - 2026.11
311 people346 people
20-29
30-39
40-49
50-59
60-69
70-79
80+
Gender Distribution2025.03 - 2026.11
63%37%
63 : 37
Explore Live Biobank Data
Experience the new paradigm of drug development firsthand